The gut-liver axis in nonalcoholic fatty liver disease: Another pathway to insulin resistance? (Q83932867)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19475679%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

editorial

0 references

title

The gut-liver axis in nonalcoholic fatty liver disease: Another pathway to insulin resistance? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19475679%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

0 references

1 reference

1 reference

metabolic dysfunction–associated steatotic liver disease

1 reference

Ester Vanni

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19475679%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Elisabetta Bugianesi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19475679%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

language of work or name

English

0 references

publication date

1 June 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19475679%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19475679%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19475679%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19475679%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

1790-1792

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19475679%20AND%20SRC:MED&resulttype=core&format=json

Gut Microbiota and Its Possible Relationship With Obesity

29 January 2020

cites work

1 reference

7 January 2021

Non-alcoholic fatty liver disease: lumen–liver interactions and possible role for probiotics

1 reference

7 January 2021

Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis

1 reference

7 January 2021

The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis

1 reference

7 January 2021

Ciprofloxacin suppresses bacterial overgrowth, increases fasting insulin but does not correct low acylated ghrelin concentration in non-alcoholic steatohepatitis

1 reference

7 January 2021

High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis.

1 reference

7 January 2021

Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease.

1 reference

7 January 2021

Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis

1 reference

7 January 2021

The gut microbiota as an environmental factor that regulates fat storage

1 reference

7 January 2021

Obesity alters gut microbial ecology

1 reference

7 January 2021

An obesity-associated gut microbiome with increased capacity for energy harvest

1 reference

7 January 2021

Microbial ecology: human gut microbes associated with obesity

1 reference

7 January 2021

Metabolic endotoxemia initiates obesity and insulin resistance

1 reference

7 January 2021

Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin

1 reference

7 January 2021

Energy intake is associated with endotoxemia in apparently healthy men.

1 reference

7 January 2021

Complexity of type 2 diabetes mellitus data sets emerging from nutrigenomic research: a case for dimensionality reduction?

1 reference

7 January 2021

TLR4 links innate immunity and fatty acid-induced insulin resistance

1 reference

7 January 2021

Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice

1 reference

7 January 2021

Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia.

1 reference

7 January 2021

Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease

1 reference

7 January 2021

Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.23036

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19475679%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference